These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31594683)

  • 21. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
    Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
    JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
    Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
    Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Cuadrado A; Llerena S; Cobo C; Pallás JR; Mateo M; Cabezas J; Fortea JI; Alvarez S; Pellón R; Crespo J; Echevarría S; Ayesa R; Setién E; Lopez-Hoyos M; Crespo-Facorro B; Agüero J; Chueca N; Garcia F; Calleja JL; Crespo J
    Am J Gastroenterol; 2018 Nov; 113(11):1639-1648. PubMed ID: 29946175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
    Buti M; Domínguez-Hernández R; Casado MÁ; Sabater E; Esteban R
    PLoS One; 2018; 13(11):e0208036. PubMed ID: 30485377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How would China achieve WHO's target of eliminating HCV by 2030?
    Li M; Zhuang H; Wei L
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):763-773. PubMed ID: 31578079
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    Müllhaupt B; Bruggmann P; Bihl F; Blach S; Lavanchy D; Razavi H; Robbins Scott S; Semela D; Negro F
    PLoS One; 2018; 13(12):e0209374. PubMed ID: 30596701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tests and screening strategies for the diagnosis of hepatitis C.
    Carey W
    Cleve Clin J Med; 2003 Sep; 70 Suppl 4():S7-13. PubMed ID: 14558640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain.
    Juanbeltz R; Pérez-García A; Aguinaga A; Martínez-Baz I; Casado I; Burgui C; Goñi-Esarte S; Repáraz J; Zozaya JM; San Miguel R; Ezpeleta C; Castilla J;
    PLoS One; 2018; 13(12):e0208554. PubMed ID: 30513107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus.
    Pérez-García A; Aguinaga A; Navascués A; Castilla J; Ezpeleta C
    Int J Infect Dis; 2019 Dec; 89():131-136. PubMed ID: 31580940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global burden of hepatitis C: considerations for healthcare providers in the United States.
    Averhoff FM; Glass N; Holtzman D
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S10-5. PubMed ID: 22715208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
    Mangia A; Albanese AP; Bourliére M; Craxi A; Dieterich D; Solomon S; Vanstraelen K; Hernandez C; Turnes J
    Adv Ther; 2021 Mar; 38(3):1397-1403. PubMed ID: 33590446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point of Care Policy for Eliminating Hepatitis C, its Applicability and Acceptability.
    Sheikh M; Poustchi H
    Arch Iran Med; 2018 Sep; 21(9):425-427. PubMed ID: 30221534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
    Kondili LA; Craxì A; Aghemo A
    Liver Int; 2021 Apr; 41(4):649-655. PubMed ID: 33486885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceeding Report of Joint Meeting of Nepalese Association for the Studies of the Liver and Nepalese Society of Gastroenterologists on Overcoming the Challenges for Hepatitis C Virus Elimination in Nepal by 2030.
    ;
    JNMA J Nepal Med Assoc; 2017; 56(206):288-290. PubMed ID: 28746332
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
    Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
    Grebely J; Applegate TL; Cunningham P; Feld JJ
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1109-1115. PubMed ID: 29088981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.